publication venue for
- Impact of an Individualized Pain Plan to Treat Sickle Cell Disease Vaso-occlusive Episodes in the Emergency Department.. 8:5330-5338. 2024
- CNS Bridging Radiotherapy Achieves Rapid Cytoreduction Prior to CAR T Cell Therapy for Aggressive B-Cell Lymphoma.. 8:5192-5199. 2024
- Guideline Concordance of Aspirin Use for Primary Prevention in Adult Outpatients. 2024
- Febrile Neutropenia in Patients with Duffy-null Associated Neutrophil Counts and Multiple Myeloma or AL amyloidosis. 2024
- Optimization of Older Adults by a Geriatric Assessment-Guided Multidisciplinary Clinic Prior to CAR T-Cell Therapy.. 8:3785-3797. 2024
- Utility or Futility? A Contemporary Approach to Allogeneic Hematopoietic Cell Transplant in TP53-Mutated MDS and AML.. 8:553-561. 2024
- Socioeconomic determinants of the biology and outcomes of acute lymphoblastic leukemia in adults.. 8:164-171. 2024
- Telehealth serious illness care program for older adults with hematologic malignancies: a single-arm pilot study.. 7:7597-7607. 2023
- More intensive therapy as more effective treatment for frail patients with multiple myeloma [corrected].. 7:6275-6284. 2023
- Higher graft cell dose does not influence development of acute or chronic GVHD in haploidentical transplantation using PTCy.. 7:4475-4478. 2023
- In-person and virtual assessment of short physical performance battery test in older adults with myeloid malignancies.. 7:4414-4417. 2023
- Analysis of Disparities in Time to Allogeneic Transplantation in Adults with Acute Myelogenous Leukemia.. 7:3824-3833. 2023
- Prospective Geriatric Assessment and Geriatric Consultation in CAR T-cell Therapy for Older Lymphoma Patients.. 7:3501-3505. 2023
- Adaptation of Serious Illness Care Program to be Delivered via Telehealth for Older Patients with Hematologic Malignancy.. 7:1871-1884. 2023
- Open-Label, Pilot Study of Romiplostim for Thrombocytopenia After Autologous Hematopoietic Cell Transplantation.. 7:1536-1544. 2023
- Pembrolizumab for the treatment of disease relapse after allogeneic hematopoietic stem cell transplantation.. 7:963-970. 2023
- A phase 1 trial utilizing TMI with fludarabine-melphalan in patients with hematologic malignancies undergoing second allo-SCT.. 7:285-292. 2023
- A validated composite comorbidity index predicts outcomes of CAR T-cell therapy in patients with diffuse large B cell lymphoma. 2023
- Dynamic EASIX Scores Closely Predict Nonrelapse Mortality After Allogeneic Hematopoietic Cell Transplantation.. 6:5898-5907. 2022
- Adapting a patient-centered communication tool for older patients with acute myeloid leukemia and their oncologist.. 6:5707-5710. 2022
- Racial Disparities in Access to Alternative Donor Allografts Persist in the Era of "Donors for All".. 6:5625-5629. 2022
- Virtual frailty assessment for older adults with hematologic malignancies.. 6:5360-5363. 2022
- Outcomes of Allogeneic Hematopoietic Cell Transplantation in Adults with Fusions Associated with Ph-like ALL.. 6:4936-4948. 2022
- A single-arm pilot study of a mobile health exercise intervention (GO-EXCAP) in older patients with myeloid neoplasms.. 6:3850-3860. 2022
- Comparative outcomes for mature T-cell and NK/T-cell lymphomas in people with and without HIV and to AIDS-defining lymphomas.. 6:1420-1431. 2022
- The Simplified Comorbidity Index: a new tool for prediction of nonrelapse mortality in allo-HCT.. 6:1525-1535. 2022
- Portable medical orders and end-of-life measures in acute myeloid leukemia and myelodysplastic syndromes.. 5:5554-5564. 2021
- A new murine Rpl5 (uL18) mutation provides a unique model of variably penetrant Diamond-Blackfan anemia.. 5:4167-4178. 2021
- Clinical predictors of poor outcomes in patients with sickle cell disease and COVID-19 infection.. 5:207-215. 2021
- The effect of red blood cell transfusion on fatigability after hospital discharge.. 4:5690-5697. 2020
- Decisional involvement and information preferences of patients with hematologic malignancies.. 4:5492-5500. 2020
- Outcomes in patients with DLBCL treated with commercial CAR T cells compared with alternate therapies.. 4:4669-4678. 2020
- Successful transfer of anti-SARS-CoV-2 immunity using convalescent plasma in an MM patient with hypogammaglobulinemia and COVID-19.. 4:4864-4868. 2020
- American Society of Hematology 2020 guidelines for treating newly diagnosed acute myeloid leukemia in older adults.. 4:3528-3549. 2020
- Geriatric assessment in older alloHCT recipients: association of functional and cognitive impairment with outcomes.. 4:2810-2820. 2020
- Impact of exercise on the immune system and outcomes in hematologic malignancies.. 4:1801-1811. 2020
- Anthracycline-related cardiotoxicity in older patients with acute myeloid leukemia: a Young SIOG review paper.. 4:762-775. 2020
- Results from a multidisciplinary clinic guided by geriatric assessment before stem cell transplantation in older adults.. 3:3488-3498. 2019
- Burden and impact of multifactorial geriatric syndromes in allogeneic hematopoietic cell transplantation for older adults.. 3:12-20. 2019
- Geriatric assessment in acute myeloid leukemia: current and future landscape.. 2:-. 2018
- Increased acute care utilization in a prospective cohort of adults with sickle cell disease.. 2:2412-2417. 2018
- Third-party fecal microbiota transplantation following allo-HCT reconstitutes microbiome diversity.. 2:745-753. 2018
- Disease severity and slower psychomotor speed in adults with sickle cell disease.. 1:1790-1795. 2017